• Login
    View Item 
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of TUScholarShareCommunitiesDateAuthorsTitlesSubjectsGenresThis CollectionDateAuthorsTitlesSubjectsGenres

    My Account

    LoginRegister

    Help

    AboutPeoplePoliciesHelp for DepositorsData DepositFAQs

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    MUTAGENESIS OF AAV CAPSID PROTEINS FOR ENHANCED TRANSDUCTION OF CARDIAC CELL TYPES

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    TETDEDXBowman-temple-0225M-120 ...
    Size:
    1.230Mb
    Format:
    PDF
    Download
    Genre
    Thesis/Dissertation
    Date
    2015
    Author
    Bowman, Latricia
    Advisor
    Rabinowitz, Joseph
    Committee member
    Eguchi, Satoru
    Recchia, Fabio
    Department
    Biomedical Sciences
    Subject
    Virology
    Biology, Molecular
    Genetics
    Permanent link to this record
    http://hdl.handle.net/20.500.12613/2617
    
    Metadata
    Show full item record
    DOI
    http://dx.doi.org/10.34944/dspace/2599
    Abstract
    Background: Adeno- associated virus serotype 9 (AAV9) has a high transduction efficiency for cardiac tissues, along with liver, skeletal muscle, pancreatic tissue, and the eye, versus other AAV serotypes. Unfortunately, nonspecific targeting to the intended tissue can result in the need for use of higher particle numbers to obtain intended transduction of the target tissue, which may also increase chances of initiating innate and adaptive immune responses. Such limitations require the need to bioengineer AAV9, and other serotypes including AAV6 and AAV8, in order to develop recombinant AAV vectors with cardiac tissue specific targeting and altered surface antigenic properties that may evade phosphorylation mediated degradation, neutralization, and clearance. Methods: Random mutagenesis PCR was used to mutate the external surface domains of AAV9 and chimeric AAV9-2 capsids. Mutations in the VP3 capsid sequences, cloned into helper plasmids pXR9 and chimeric pXR9-2 (substituting the 3-fold loop region of AAV9's VP3 with AAV2's), were used to generate a small library of rAAV9 or chimeric 9-2 vectors with mutant capsids. For accurate comparison, parent plasmids AAV9-2, AAV9 and AAV2 (with no mutations) were also used to generate rAAV vectors, each packaging the luciferase transgene. Mutant or parent vectors expressing luciferase were used to transduce HEK293 cells (HEK293s), neonatal cardiomyocytes (NCMs), and neonatal or adult rat cardiac fibroblasts (RCFs), in vitro (1,000 vp/cell). Relative luciferase activities and protein concentrations were measured (RLU/ug/uL), respectively. A second approach at mutagenesis of the pXR9-2 capsid was employed. Surface-exposed T and Y residues were substituted for Valine or Phenylalanine and an ischemic myocardium targeting peptide (ICTP) motif was inserted at site 588 of the VP1 capsid protein. Results: A small library of mutant rAAV9 or 9-2 vectors was screened in HEK293s, NCMs, and RCFs in vitro. Luciferase assay results led to the selection of several mutants, believed to have enhanced levels of transgene expression. After large scale production of mutant and parent vectors, in vitro transduction assays revealed mutant vectors did not transduce NCMs or RCFs cultures better than their respective parent vectors. Recombinant AAV9-2R mutants, containing all or some point mutations and/or ICTP, produced similar results. Some mutants exhibited changes in tropism properties that were different from the parent vectors. Still, parent vector AAV9-2 displayed robust transduction efficiency, much greater than the other parent or mutant vectors. These results encourage us to continue our investigation into its unique properties. Conclusions: This study reflects the difficulties of AAV capsid mutagenesis. We hope that this study can serve as a tool to further our understanding of AAV's molecular and structural biology properties.
    ADA compliance
    For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
    Collections
    Theses and Dissertations

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Temple University Libraries | 1900 N. 13th Street | Philadelphia, PA 19122
    (215) 204-8212 | scholarshare@temple.edu
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.